Quantcast
Last updated on April 21, 2014 at 12:39 EDT

Latest Gilead Sciences Stories

2013-03-07 16:24:12

WHITE PLAINS, N.Y., March 7, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is pleased to announce an expanded role for Chief Policy and Advocacy Officer Mark Velleca, M.D., Ph.D. Velleca, who has headed LLS's Office of Public Policy in Washington, D.C., since early 2012, will now oversee the newly integrated patient advocacy, policy and programs department. Velleca will continue to oversee the strategy and implementation of LLS's growing legislative and regulatory policy...

2013-03-04 12:28:19

PrEP Strategies Remain Valuable Prevention Tool, says AVAC NEW YORK, March 4, 2013 /PRNewswire-USNewswire/ -- Results from a large-scale HIV prevention trial among African women known as VOICE (Vaginal and Oral Interventions to Control the Epidemic) provide an urgent reminder that products must meet the needs of the people using them. While disappointing, the results lend new urgency and direction to the search for additional safe and effective HIV prevention options for women, AVAC said...

2013-03-01 08:27:37

HONG KONG, March 1, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports and equity research for the following companies: Groupon (NASDAQ:GRPN), Bank of America (NYSE:BAC), QUALCOMM (NASDAQ:QCOM), JPMorgan Chase (NYSE:JPM), Lowe's (NYSE:LOW), and Gilead Sciences (NASDAQ:GILD). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)...

2013-02-23 23:02:35

According to the World Health Organization (WHO) 350,000 people a year are dying from Hepatitis C. Gilead Sciences and Bristol-Myers Squibb together developed a promising cure and HCV advocates are outraged at lack of its development San Antonio, Texas (PRWEB) February 23, 2013 According to the World Health Organization, (WHO) 350,000 people die each year from Hepatitis C and it is the most widespread blood borne infection in the country....

2013-02-21 12:21:17

CHICAGO, Feb. 21, 2013 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Toyota Motor Corp. (NYSE:TM), General Motors Company (NYSE:GM), Volkswagen AG (OTC:VLKAY), Honda Motor Co. (NYSE:HMC) and Gilead Sciences (Nasdaq:GILD). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO)...

2013-02-08 16:22:31

FOSTER CITY, CA, Feb. 8, 2013 /PRNewswire/ - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has completed its acquisition of YM BioSciences Inc. (NYSE MKT: YMI, TSX: YM). On February 8, 2013, a subsidiary of Gilead acquired all of the outstanding common shares of YM pursuant to the terms of a plan of arrangement. As a result, YM has become a wholly-owned subsidiary of Gilead and it is anticipated that the common shares of YM will no longer be listed for trading on the...

2013-02-05 12:27:40

MISSISSAUGA, ON, Feb. 5, 2013 /PRNewswire/ - YM BioSciences Inc. (NYSE MKT: YMI, TSX: YM) (the "Company" or "YM") is pleased to announce that the Supreme Court of Nova Scotia has issued a final order approving the previously announced plan of arrangement (the "Arrangement") involving the Company, Gilead Sciences, Inc. ("Gilead") and 3268218 Nova Scotia Limited, a wholly-owned subsidiary of Gilead (the "Purchaser").   Under the Arrangement, the Purchaser will acquire all of the...

2013-02-04 08:31:25

HONG KONG, Feb. 4, 2013 /PRNewswire/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and equity research for the following companies: National-Oilwell Varco (NYSE:NOV), Gilead Sciences (NASDAQ:GILD), Dow Chemical (NYSE:DOW), Chesapeake Energy (NYSE:CHK), Barrick Gold (NYSE:ABX), and ConocoPhillips (NYSE:COP). (Logo: http://photos.prnewswire.com/prnh/20130130/HK50859LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to...

2013-01-31 12:28:29

MISSISSAUGA, ON, Jan. 31, 2013 /PRNewswire/ - YM BioSciences Inc. (NYSE MKT: YMI, TSX: YM) (the "Company" or "YM") is pleased to announce that, at the special meeting (the "Meeting") of shareholders of the Company (the "YM Shareholders") held earlier today, the YM Shareholders approved the previously announced plan of arrangement (the "Arrangement") involving the Company, Gilead Sciences, Inc. ("Gilead") and 3268218 Nova Scotia Limited, a wholly-owned subsidiary of Gilead (the...

2013-01-30 04:21:16

LONDON, January 30, 2013 /PRNewswire/ -- EmergingGrowth.com, a leading digital financial media company, discusses Sunesis Pharmaceuticals, Amgen, Inc., Gilead Sciences and Biogen Idec, Inc. The pharmaceutical sector is a very lucrative and competitive industry. And for emerging growth companies, it is difficult to make a meaningful impact in this cutthroat industry. Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) has built a highly experienced cancer drug development...